Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05926960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-04-03
Brief Title:
A Study Comparing 3 Study Medicines Encorafenib Binimetinib Pembrolizumab to 2 Study Medicines Ipilimumab and Nivolumab in Patients With Advanced Melanoma
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-23
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-03
First Submit QC Date:
June 23 2023
Study First Post Date:
2023-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-05
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL